| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |